MethylphenIdate for Fatigue in Haematological Cancer

NCT03218254 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hematological Cancer

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

Henrik Frederiksen